NIPH Clinical Trials Search

Detection of sentinel lymph node in uterine cancer

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Uterine Cervical Cancer, Uterine Corpus Cancer
Date of first enrollment	25/08/2025
Target sample size	10
Countries of recruitment
Study type	Interventional
Intervention(s)	sentinel lymph node biopsy

Outcome(s)

Primary Outcome	Assessment of Safety Related to the Examination/Procedure Complications to be monitored include anaphylaxis, vascular or nerve injury, and other adverse events commonly associated with surgical treatment for malignant tumors in routine clinical practice.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Female
Include criteria	Patients diagnosed with cervical cancer or endometrial cancer at the Department of Obstetrics and Gynecology of our hospital between the date of iRCT publication and March 31, 2027, who are scheduled to undergo surgical treatment. Age over 20 years at the time of informed consent. Written informed consent was obtained from the patient for participation in the study.
Exclude criteria	Patients in whom preoperative imaging suggests lymph node metastasis. Patients who have received prior treatment such as radiotherapy or chemotherapy before surgery. Patients with a history of hypersensitivity to indocyanine green or iodinated contrast agents. Patients deemed otherwise inappropriate for inclusion in the study at the discretion of the attending physician.